The latest developments

Hear speakers from all sides of the industry present and discuss their requirements and solutions.

Future trends

Find out what is in store for the industry, with the advent of new technological advances and regulatory requirements for the development of DPI and Soft Mist Inhalers.

Networking

Meet the people who are going to be making a difference. Get to know the ‘movers and shakers’ in the industry

Exhibition

Get hands-on experience of the latest there is on offer, and meet the people who made them.

InspireMe promises to be the DPI and Soft Mist industry event of the year.

Attendance is essential for everyone in the industry who needs to stay up to date with respiratory pharmaceutical and technological developments, find out what’s coming next and meet the key players in the industry.

Thought leaders, trailblazers and the influential voices will be sharing their ideas in relation to dry powder and soft mist inhalers. Spread over two days, with Day 1 focusing on DPI technology and Day 2 on Soft Mist Technology, the aim of the event is to inspire new ideas in the development, manufacture and regulatory approval of DPI and Soft Mist Inhalers.

This event presents an opportunity to meet with industrialists, academics and suppliers in the DPI and Soft Mist Inhaler arena. Exhibitors at the event look forward to providing a hands on experience of their products and technologies.

There’ll be many opportunities to meet them and your peers, as well as to gain hands on experience of the products and technologies at the exhibition.

Hosted at the AC Hotel San Francisco Airport/Oyster Point in South San Francisco, InspireMe provides an opportunity to meet peers from around the world in the Biotech hub, within the heart of Southern San Francisco.

At the AC Hotel San Francisco Airport/Oyster Point Waterfront

Free to Register until May 31st, 2019. Attendance, food and beverages at the InspireMe event are provided free of charge.

Register Now for FREE

Event Agenda: Day 1 – DPI

Start Time End Time Activity
08:00am 08:45am Registration with continental Breakfast
08:45am 09:15am Dr. Ralph Niven – PhD, MBA, Inhalation Consultant
09:15am 10:45am Nanopharm 09:15 – 09:45: “Utilising the SmartTrackTM Pathway to Accelerate the Development of Dry Powder Inhalers” - Dr Jag Shur, CEO, Nanopharm Ltd.

Merxin 09:45 – 10:45: “Capsule and Multidose DPI: How to make a choice” – Dr Philippe Rogueda, CBO.
10:45am 11:15am AM break with tea, coffee, water, assorted Greek yoghurt, granola and cut fruits
11:15am 12:45pm Meggle 11:15 – 11:45: “Lactose for Dry Powder Inhalers: Formulation Strategies” – Dr Mirjam Kobler, Head of R&D Excipients & Technology.

Harro Hofliger 11:45 – 12:45: ”Powder Dosing and DPI Manufacturing Technologies” – Marco Laackmann, Dipl.-Ing. (FH), MBA, Director Inhalation Technology.
12:45pm 1:45pm Hot buffet lunch for all sponsors and delegates
1:45pm 3:15pm Lonza 1:45 – 2:30: “Customization of DPI Capsules to Optimize Compatibility and Delivery” - Dr Matt Richardson, Manager, Pharmaceutical Business Development, Capsugel (division of Lonza).

Proveris 2:30 – 3:15: “A new paradigm for BAI and DPI Analysis: Inhalation product testing under human realistic conditions” – Ms. Heli Chauhan, Senior Application Chemist.
3:15pm 3:45pm PM break with tea, coffee, water, granola bars, gourmet mixed nuts and assorted smoothies
3:45pm 4:30pm Prof. Hugh Smyth – PhD, University of Texas, Molecular Pharmaceuticals and Drug Delivery.
4:30pm 4:45pm Closing remarks and questions to sponsors

Event Agenda: Day 2 – Soft Mist

Start Time End Time Activity
08:00am 09:00am Registration with continental Breakfast
09:00am 10:30am Merxin 09:00 – 9:45: “What no one tells you about Soft Mist Inhalers” – Mr Graham Purkins, CTO.

Med HF 09:45 – 10:30: “Inhalation devices:  When are Human Factors studies required” – Lee Wood, Co-Founder/ Managing Director.
10:30am 11:00am AM break with tea, coffee, water, assorted Greek yoghurt, granola and cut fruits
11:00am 12:30pm Proveris 11:00 – 11:45: “Critical Quality Attributes (CQAs) comparison between soft mist and pressured metered dose inhaler” - Ms. Heli Chauhan, Senior Application Chemist.

Harro Hofliger 11:45 – 12:30: “Challenges for design, manufacturing and up-scaling of soft mist inhaler” - Marco Laackmann, Dipl.-Ing. (FH), MBA, Director Inhalation Technology.
12:30pm 1:30pm Hot buffet lunch for all sponsors and delegates
1:30pm 3:00pm Malvern 1:30 – 2:15: “Advances in the alternative bioequivalence guidance for solution based orally inhaled products: SmartTrack to the rescue!” - Dr Jag Shur, CEO, Nanopharm Ltd.

Nanopharm 2:15 – 3:00: “Droplet Dynamics in Soft Mist Inhalers” – Dr William Ganley, Head of Regulatory Science.
3:00pm 3:30pm PM break with tea, coffee, water, granola bars, gourmet mixed nuts and assorted smoothies
3:30pm 4:15pm Dr Jason McConville – PhD, University of New Mexico, Department of Pharmaceutical Sciences.
4:15pm 4:45pm Closing remarks and questions to sponsors

Our Speakers – Day 1

CEO, NANOPHARM LTD

Utilizing the SmartTrack™ Pathway to Accelerate the Development of Dry Powder Inhalers.

Dr Jag Shur is CEO and a hands-on manager of Nanopharm Ltd who has managed the successful growth of Nanopharm. He has over 15 years of experience in the development of orally inhaled and nasal drug products in both industry and academia, having held positions at Profile Therapeutics (Philips), GlaxoSmithKline and the University of Bath.

Jag has a First Degree in Chemistry, received his PhD in Inhaled Biopharmaceutics and has authored more than 30 scientific papers.

CBO, MERXIN

Capsule and Multidose DPI: How to Make a Choice.

Co-founder of Merxin Ltd, Philippe is a formulation expert with a global reputation.

He is a Fellow of the Woolcock Respiratory Institute at Sydney University, and formerly Executive Director at Actavis Pharma, where he set up their generic inhalation pipeline. He has an enviable track record in developing pMDI, DPI, Nebules, Nasal and Soft Mist Inhalers in both generic and originator companies.

He recently founded Anthocan Ltd, a company dedicated to inhaled cannabinoid therapies.

Merxin is a designer, developer and supplier of generic and customised drug delivery and medical device platforms.

Head of R&D Excipients & Technology, Meggle

Lactose for Dry Powder Inhalers – Formulation Strategies.

Dr Mirjam Kobler holds a PhD in Physical Chemistry from the University of Munich.

She started work in the MEGGLE R&D Department in 2013 as a Project Manager for Analytical Development, especially in the field of Dry Powder Inhalers. In 2016 she became Senior Project Manager for DPI Excipients, with responsibilities in product development, technical support and characterization techniques.

Her background includes five years of experience in various areas of lactose as an excipient, especially in lactose for Dry Powder Inhalers. In February 2018 she was promoted to Head of the R&D Department of the MEGGLE Business Group Excipients and technology.

MEGGLE Excipients and Technology is a global leader in manufacturing lactose for the pharmaceutical industry.

DIRECTOR INHALATION TECHNOLOGY, HARRO HÖFLIGER

Powder Dosing and DPI Manufacturing Technologies.

Marco Laackmann’s background includes 15 years of experience in various areas of Dry Powder Inhaler covering aspects of device development, manufacturing and quality control of medical devices as well as powder dosing technologies and process development.

He has worked for P&G in Packaging Development of Fast Moving Consumer Goods, followed by a position of Packaging and Device Technology in Boehringer Ingelheim’s department of Spiriva® Launch. In 2007 he became manager of Quality, Supply Chain and Medical Device Sales in RPC Formatec.

Since April 2011, Marco Laackmann has worked in Harro Höfliger, where he is Business Unit Leader Inhalation responsible for global business development, product management and project management of machinery for the Dry Powder Inhaler pharma industry.

His has an Engineering Degree in Chemical Engineering Applied Biotechnology from the University of Applied Science, Emden, Germany and an MBA from the Bradford School of Management, UK.

MANAGER, PHARMACEUTICAL BUSINESS DEVELOPMENT, CAPSUGEL (DIVISION OF LONZA)

Customization of DPI Capsules to Optimize Compatibility and Delivery.

For more than 13 years, Matt has worked with many pharmaceutical and nutraceutical customers to understand the formulation and delivery aspects of their products with two-piece hard capsules.

Matt has been an invited speaker at numerous seminars and webinars on topics of hard capsules, polymer science, gelatin crosslinking, capsules for use in delayed release, as well as DPI-based inhalation.

He has additional background experience in synthetic API development, process development and project management.

Matt is a graduate of Wofford College, holds a doctorate in Synthetic Organic Chemistry from Wake Forest University and a post-doctoral appointment at Virginia Tech.

SENIOR APPLICATION CHEMIST, PROVERIS SCIENTIFIC

A New Paradigm for BAI and DPI Analysis: Inhalation Product Testing Under Human Realistic Conditions.

Heli Chauhan is the laboratory manager at Proveris Laboratories for new study protocols, technology transfer, and method optimization. She is also the primary contact working with customers on development and QC projects.

Heli has served in quality control and development roles in the pharmaceutical industry, commercializing products in a range of dosage forms including sprays, inhalers, injectables and solid dosage forms. She is the author of numerous scientific papers and posters illustrating a Quality by Design approach for successful development and commercialization of innovator and generic drug products.

She is applying her experience to expand the DPI/BAI analysis technology.

UNIVERSITY OF TEXAS, MOLECULAR PHARMACEUTICALS AND DRUG DELIVERY

Our Speakers – Day 2

CTO, MERXIN

What No-one Tells you About Soft Mist Inhalers.

Co-founder of Merxin Ltd, Graham is a Chartered Engineer and medical device expert with an accomplished track record delivering technology and global projects across R&D and commercial industrialization.

Previous positions include Head of Hardware Development at 3M Health Care, Device Engineering Group Manager at Novartis and Programme Manager at Bespak, leading the construction and setting up of the UK’s largest clean room manufacturing facility, for the Mylan generic Advair DPI platform.

CO-FOUNDER/MANAGING DIRECTOR, MEDHF

Inhalation Devices: When are Human Factors Studies Required.

Lee Wood is the Co-Founder and Managing Director of medHF. Previously Lee was the Head of Human Factors Engineering at Roche Pharma, a Principal Human Factors Scientist at Novartis Pharma and a Senior Product Designer at Cambridge Consultants. Lee holds a First-class BSc (Hons) in Product Design from the University of Wales, UK and an MSc with Distinction in Healthcare Human Factors Engineering from the University of Derby, UK. He is a Chartered Product Designer.

medHF is a specialist Human Factors Engineering Consultancy based in Basel (CH) with offices in London (UK), Hamburg (DE) and Columbus (US). medHF supports it clients by running Human Factors studies at the formative and summative/validation stages of development and provides expert consulting services on Human Factors strategy, Use-Related Risk management, Instructions for Use development, Design Validation and Regulatory submission authoring and review (including Threshold Analysis and Human Factors Summary Reports).

medHF has an ISO13485:2016 certified quality system and regularly works with many of the world’s top 10 pharmaceutical and drug-delivery device companies.

SENIOR APPLICATION CHEMIST, PROVERIS SCIENTIFIC

Critical Quality Attributes (CQAs) Comparison Between Soft Mist and Pressured Metered Dose Inhaler.

Heli Chauhan is the laboratory manager at Proveris Laboratories for new study protocols, technology transfer, and method optimization. She is also the primary contact working with customers on development and QC projects.

Heli has served in quality control and development roles in the pharmaceutical industry, commercializing products in a range of dosage forms including sprays, inhalers, injectables and solid dosage forms. She is the author of numerous scientific papers and posters illustrating a Quality by Design approach for successful development and commercialization of innovator and generic drug products.

Her experience has proven valuable to our customers using soft mist products.

DIRECTOR INHALATION TECHNOLOGY, HARRO HÖFLIGER

Challenges for Design, Manufacturing and Up-scaling of Soft Mist Inhaler.

Marco Laackmann’s background includes 15 years of experience in various areas of Dry Powder Inhaler covering aspects of device development, manufacturing and quality control of medical devices as well as powder dosing technologies and process development.

He has worked for P&G in Packaging Development of Fast Moving Consumer Goods, followed by a position of Packaging and Device Technology in Boehringer Ingelheim’s department of Spiriva® Launch. In 2007 he became manager of Quality, Supply Chain and Medical Device Sales in RPC Formatec.

Since April 2011, Marco Laackmann has worked in Harro Höfliger, where he is Business Unit Leader Inhalation responsible for global business development, product management and project management of machinery for the Dry Powder Inhaler pharma industry.

His has an Engineering Degree in Chemical Engineering Applied Biotechnology from the University of Applied Science, Emden, Germany and an MBA from the Bradford School of Management, UK.

CEO, NANOPHARM LTD

Advances in the Alternative Bioequivalence Guidance for Solution Based Orally Inhaled Products: SmartTrack™ to the Rescue!

Dr Jag Shur is CEO and a hands-on manager of Nanopharm Ltd who has managed the successful growth of Nanopharm. He has over 15 years of experience in the development of orally inhaled and nasal drug products in both industry and academia, having held positions at Profile Therapeutics (Philips), GlaxoSmithKline and the University of Bath.

Jag has a First Degree in Chemistry, received his PhD in Inhaled Biopharmaceutics and has authored more than 30 scientific papers.

HEAD OF REGULATORY SCIENCE, NANOPHARM LTD

Droplet Dynamics in Soft Mist Inhalers.

William received a PhD in Colloid Science from the University of Bristol for which he was awarded both the Physical Sciences Award and the Best Thesis in the Faculty of Science Prize. His research involved the physical characterisation of dispersed systems that are commonly encountered in industrial formulations. He then completed a postdoc at the University of Bath with Professor Robert Price where he developed an interest in combining experiments and modelling to better understand pharmaceutical products.

He now works at Nanopharm as Head of Regulatory Science where he continues to develop innovative methods to improve our understanding of inhaled pharmaceutical products and has published multiple peer reviewed research papers and conference proceedings in the fields of physical chemistry and pharmaceutics.

UNIVERSITY OF NEW MEXICO, DEPARTMENT OF PHARMACEUTICAL SCIENCES

Event Location

AC Hotel San Francisco Airport / Oyster Point Waterfront

1333 Veterans Blvd., South San Francisco, CA 94080

Telephone: +1 650-742-9211

Registration

Free to Register until May 31st, 2019. Attendance, food and beverages at the InspireMe event are provided free of charge.

Specially negotiated room rates for the AC Hotel San Francisco Airport hotel are available during the event. Please telephone +1 650-742-9211

Day One Only
Day Two Only
Both Days